Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/6/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. William D. Kerns

Wrong Dr. William D. Kerns?

Chief Executive Officer

Phone: (978) ***-****  
Local Address:  Waltham , Massachusetts , United States
Synchroneuron Inc
130 Tobey Garden Street
Duxbury , Massachusetts 02332
United States

Company Description: Synchroneuron was founded in 2011 by inventor and neurologist Dr. Barry Fogel, a clinical professor of psychiatry at Harvard Medical School, and the principals of...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • DVM
  • MS
  • PhD
  • D.V.M.
86 Total References
Web References
Synchroneuron | Management Team
www.synchroneuron.com, 17 Aug 2015 [cached]
William D Kerns DVM, MS, DACVP Interim CEO
Dr. Kerns is an entrepreneur and co-founder of Synchroneuron Inc. He completed his medical training in Veterinary Medicine and graduate work in Pharmacology and Pathology at The Ohio State University. In his graduate program, he studied molecular mechanisms of cardiac hypertrophy. In 1980, he successfully completed examination by the American College of Veterinary Pathologists.
Dr. Kerns has 30 years of experience in pharmaceutical research and development, having held senior executive positions in preclinical development at SmithKlineFrench, SmithKlineBeecham, and Eisai during his pharmaceutical career. He is recognized as an expert in drug development and safety assessment and an expert on mechanisms of drug-induced cardiovascular toxicity. He has authored or co-authored over 100 articles and has co-edited a book on cardiovascular toxicology. He has been actively involved in the SOT, STP and ACVP and he has co-chaired an FDA expert committee on biomarkers of drug-induced vascular injury. .
Dr. Kerns has participated in the successful management and activation of over 200 INDs and 15 NDAs during his career. Currently he oversees the submission of 3-4 INDs each year across multiple divisions at FDA. .
Dr. Kerns is also a co-founder and the CEO of Accellient Partners, LLC, a drug development consultancy in Waltham, MA.
Synchroneuron | Board of Directors
www.synchroneuron.com, 17 Aug 2015 [cached]
William D Kerns DVM, MS Interim CEO
Dr. Kerns is an entrepreneur and co-founder of Synchroneuron Inc. He completed his medical training in Veterinary Medicine and graduate work in Pharmacology and Pathology at The Ohio State University. In his graduate program, he studied molecular mechanisms of cardiac hypertrophy. In 1980, he successfully completed examination by the American College of Veterinary Pathologists.
Dr. Kerns has 30 years of experience in pharmaceutical research and development, having held senior executive positions in preclinical development at SmithKlineFrench, SmithKlineBeecham (both now part of GlaxoSmithKline), and Eisai during his pharmaceutical career. He is recognized as an expert in drug development and safety assessment with a focus on mechanisms of drug-induced cardiovascular toxicity. He has authored or co-authored over 100 articles and has co-edited a book on cardiovascular toxicology. He has been actively involved in the SOT, STP and ACVP and he has co-chaired an FDA expert committee on biomarkers of drug-induced vascular injury. .
Dr. Kerns has participated in the successful management and activation of over 200 INDs and 15 NDAs during his career. Currently he oversees the submission of 3-4 INDs each year across multiple divisions at FDA.
Dr. Kerns is also a co-founder and the CEO of Accellient Partners, LLC, a drug development consultancy.
Accellient Partners | Management Team
www.accellient.com, 4 Aug 2015 [cached]
Bill Kerns, DVM, MS, DACVP Partner Chief Executive Officer
Regulatory & Drug Development
Drug Development Team
www.can-fite.com, 2 Feb 2016 [cached]
William D. Kerns, DVM, MS, DACVP, VP Drug Development
Dr. Kerns has over 20 years of experience in Pharmaceutical Research and Development at SmithKline Beecham and Eisai Pharmaceuticals. As a Senior Executive he has participated in the development of drugs for over 100 Phase I studies and 13 NDAs/MAAs. Bill has chaired a FDA committee on biomarkers and he is an expert in preclinical development and regulatory strategy.
TLC - Company - Management
www.tlcbio.com, 8 Feb 2011 [cached]
William D. Kerns DVM, MS, DACVP Dr. Kerns currently serves as the Managing Director of Aptuit Consulting Inc., specializing in areas such as managing drug development-API through Phase 2 POC; regulatory planning and IND submissions; expert witnessing for biological issues; due diligence for investment firms and pharma companies and cardiovascular drug safety. Previously Dr. Kerns was executive vice president, Global Drug Safety, Metabolism and Safety Pharmacology, for Eisai Co. Ltd. Prior to that he was group director of U.S. Preclinical Safety Assessment for SmithKline Beecham. Most recently Dr. Kerns served as chief scientific officer of Oread, Inc. until its closure in 2001.
Dr. Kerns received his DVM from The Ohio State University in 1975. He is a diplomate of the American College of Veterinary Pathologists and has been involved with or responsible for more than 50 INDs and 13 MAAs/NDAs. He has published and lectured extensively on drug-induced cardiovascular toxicity in animals and he has published more than 100 articles, chapters, and abstracts.
Other People with the name "Kerns":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304